U.S. Overactive Bladder Treatment Market Size & Outlook
U.S. overactive bladder treatment market, 2018-2030 (US$M)
Related Markets
U.S. overactive bladder treatment market highlights
- The U.S. overactive bladder treatment market generated a revenue of USD 1,263.9 million in 2023 and is expected to reach USD 1,603.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 3.5% from 2024 to 2030.
- In terms of segment, mirabegron was the largest revenue generating type in 2023.
- Neuromodulation is the most lucrative type segment registering the fastest growth during the forecast period.
Overactive bladder treatment market data book summary
| Market revenue in 2023 | USD 1,263.9 million |
| Market revenue in 2030 | USD 1,603.8 million |
| Growth rate | 3.5% (CAGR from 2023 to 2030) |
| Largest segment | Mirabegron |
| Fastest growing segment | Neuromodulation |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anticholinergics, Mirabegron, Botox, Neuromodulation, Other |
| Key market players worldwide | Pfizer Inc, AbbVie Inc, Astellas Pharma Inc, Medtronic PLC, Sumitomo Pharma Co Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd, Hisamitsu Pharmaceutical Co Inc, Par Pharmaceutical |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.3% of the global overactive bladder treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. overactive bladder treatment market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 175.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Overactive Bladder Treatment Market Scope
Overactive Bladder Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. overactive bladder treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to overactive bladder treatment market will help companies and investors design strategic landscapes.
Mirabegron was the largest segment with a revenue share of 27.59% in 2023. Horizon Databook has segmented the U.S. overactive bladder treatment market based on anticholinergics, mirabegron, botox, neuromodulation, other covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. overactive bladder treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. overactive bladder treatment market databook
-
Our clientele includes a mix of overactive bladder treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. overactive bladder treatment market, including forecasts for subscribers. This country databook contains high-level insights into U.S. overactive bladder treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. overactive bladder treatment market report size, by type, 2018-2030 (US$M)
U.S. Overactive Bladder Treatment Market Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
